Pharma Reviews: Piramal Pharma invests Rs 101.77 Cr in CDMO Yapan Bio - BioSpectrum India

Investment in biologics reflects the company's global commitment to this fast-growing segment of the pharma industry.
Read more: Piramal Pharma invests Rs 101.77 Cr in CDMO Yapan Bio - BioSpectrum India